HighPoint Advisor Group’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
DAM
HighPoint Advisor Group's RMD Position: Q1 2026 in Review
HighPoint Advisor Group sold out of ResMed (RMD) in Q1 2026, closing a stake of 2,086 shares — an estimated $503K sold.
HighPoint Advisor Group first reported a position in RMD in Q2 2019 and held it in 19 quarters. The position peaked at $612K in Q3 2024. 941 funds tracked by Wall St. Rank hold RMD as of Q1 2026.
- HighPoint Advisor Group reported no remaining ResMed position as of Q1 2026 after selling out during the quarter.
- HighPoint Advisor Group sold 2,086 ResMed shares in Q1 2026, an estimated $503K.
- HighPoint Advisor Group first reported a position in ResMed in Q2 2019 and held it in 19 quarters.
- HighPoint Advisor Group's ResMed position peaked at $612K in Q3 2024.
- 941 funds tracked by Wall St. Rank held ResMed as of Q1 2026.
Based on HighPoint Advisor Group's 13F filing for Q1 2026, filed 14 May 2026.